An Inflammatory Story: Antibodies in Tuberculosis Comorbidities
Mycobacterium tuberculosis (Mtb) resides in a quarter of the world's population and is the causative agent for tuberculosis (TB), the most common infectious reason of death in humans today. Although cellular immunity has been firmly established in the control of Mtb, there is growing evidence t...
Main Authors: | Milla R. McLean, Lenette L. Lu, Stephen J. Kent, Amy W. Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02846/full |
Similar Items
-
Serological and cellular inflammatory signatures in end‐stage kidney disease and latent tuberculosis
by: Milla R McLean, et al.
Published: (2021-01-01) -
Antibody glycosylation correlates with disease progression in SIV‐Mycobacterium tuberculosis coinfected cynomolgus macaques
by: Ebene R Haycroft, et al.
Published: (2023-01-01) -
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
by: Matthew S. Parsons, et al.
Published: (2018-08-01) -
Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis
by: Stephen M. Carpenter, et al.
Published: (2022-03-01) -
Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
by: Patricia S. Grace, et al.
Published: (2021-07-01)